
|Articles|November 8, 2018
Vivozon’s Non-Opioid PainKiller Has Been Granted the FDA’s Fast Track Designation
Advertisement
MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
